BION:SWX
Bb Biotech AG
CHF 53.20
arrow_upward
+2.31%(+1.20) 1D
Jul 31, 12:09:51 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BION...
Open
CHF 52.70
High
CHF 53.30
Low
CHF 52.20
Mkt. cap
2.93B
Avg. vol.
87.82K
Volume
49.28K
Dividend
4.23%
Quarterly dividend
CHF 0.56
Ex-dividend date
Mar 23, 2026
P/E ratio
2.17
52-wk high
CHF 53.30
52-wk low
CHF 30.75
EPS
CHF 24.51
Shares outstanding
55.15M
No. of employees
73
Open
CHF 52.70
High
CHF 53.30
Low
CHF 52.20
Mkt. cap
2.93B
Avg. vol.
87.82K
Volume
49.28K
Dividend
4.23%
Quarterly dividend
CHF 0.56
Ex-dividend date
Mar 23, 2026
P/E ratio
2.17
52-wk high
CHF 53.30
52-wk low
CHF 30.75
EPS
CHF 24.51
Shares outstanding
55.15M
No. of employees
73
News stories
From sources across the web
PR Newswire
·
36 minutes ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
28 minutes ago
Cohu, Inc. (NASDAQ: COHU) boosts Q2 2026 revenue and trims net loss
Simply Wall St
·
4 minutes ago
SpaceX (NasdaqGS:SPCX) Could Get Faster Launch Approvals Under New FAA Proposal
Seeking Alpha
·
1 hour ago
Chart Of The Day: The 'No Confidence' Trade - And What Comes Next
Profile
BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange.
It is one of the largest investment companies in the biotech sector. Wikipedia
About Bb Biotech AG
CEO-
Employees73
FoundedNov 9, 1993
HeadquartersKüsnacht, Zurich, Switzerland
SectorCapital market
Websitebbbiotech.ch
AI content may include mistakes. Learn more